Back
Macrogenics Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
64
MGNX
Macrogenics
Last Price:
3.57
Seasonality Move:
20.1%
Sell
42
APLS
Apellis Pharmaceuticals
Last Price:
26.69
Seasonality Move:
20.78%
Buy
64
Macrogenics (MGNX)
is a Buy
Is Macrogenics a Buy, Sell or Hold?
- The current Macrogenics [MGNX] share price is $3.81. The Score for MGNX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- MGNX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $28.06. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MGNX Stock Price Chart
What is Macrogenics's stock price today?
-
The Macrogenics share price today is $3.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MGNX is experiencing slight buying pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $28.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
MGNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 48.83 | Sell |
| Chaikin Money Flow: | 251427 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.59 - 4.19) | Sell |
| Bollinger Bands (100): | (3.26 - 4.5) | Sell |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 45.18 | Sell |
| Chaikin Money Flow: | -2912738 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.06 - 28.78) | Buy |
| Bollinger Bands (100): | (29.25 - 39.19) | Sell |
MGNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.1 | Sell |
| 20-day SMA: | 3.86 | Sell |
| 50-day SMA: | 3.65 | Buy |
| 200-day SMA: | 8.4 | Sell |
| 8-day EMA: | 3.99 | Sell |
| 20-day EMA: | 3.9 | Sell |
| 50-day EMA: | 3.86 | Sell |
| 200-day EMA: | 6.08 | Sell |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.85 | Sell |
| 20-day SMA: | 28.04 | Buy |
| 50-day SMA: | 30.45 | Sell |
| 200-day SMA: | 43.48 | Sell |
| 8-day EMA: | 28.61 | Sell |
| 20-day EMA: | 28.52 | Sell |
| 50-day EMA: | 30.4 | Sell |
| 200-day EMA: | 40.17 | Sell |
Macrogenics Earnings Growth & MGNX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.80 per share, and a decrease next year of $1.14 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
Macrogenics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||